Back
Neurogene Stock Predictions
Sponsored
NGNE
Sponsored
"EarnPhone": The Investment Hidden in Plain Sight
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
40
NGNE
Neurogene
Last Price:
41.53
Seasonality Move:
-0.92%
7 Day Trial
ALL ACCESS PASS
$
7
Free 23-page book shares my #1 indicator to use
Here's the 23-page free book.Neurogene Stock Forecast
- Over the next 52 weeks, Neurogene has on average historically risen by 31.2% based on the past 10 years of stock performance.
- Neurogene has risen higher in 5 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
-
Is Neurogene Stock Undervalued?
The current Neurogene [NGNE] share price is $40.27. The Score for NGNE is 40, which is 20% below its historic median score of 50, and infers higher risk than normal. - NGNE is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
Will Neurogene Stock Go Up Next Year?
- Over the next 52 weeks, Neurogene has on average historically risen by 31.2% based on the past 10 years of stock performance.
Neurogene Stock Rating
Sell
40
Neurogene (NGNE)
is a Sell
Is Neurogene overpriced?
- Neurogene has risen higher in 5 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
Neurogene Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
neurogene.com
52-Week Data
52-Week High:
53.00
52-Week Low:
12.49
Prediction Charts
Market Cap:
523.25M
Price in USD:
40.27
Volume:
106.84K
Beta:
-1.27
Technical Analysis
SMA50:
38.55
SMA100:
36.57
SMA200:
33.40
52-Wk Change:
168.47%
Stock Predictions
-
Is Neurogene stock public?
Yes, Neurogene is a publicly traded company. -
What is the Neurogene stock quote today?
The Neurogene stock price is 40.27 USD today. -
How to buy Neurogene stock online?
You can buy Neurogene shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Aug-28 | 35.50 | 35.75 | 37.42 | 35.27 |
Aug-29 | 35.91 | 36.40 | 37.42 | 35.02 |
Aug-30 | 36.90 | 37.32 | 38.17 | 35.91 |
Sep-3 | 37.10 | 32.75 | 38.00 | 32.62 |
Sep-4 | 32.32 | 34.50 | 34.70 | 32.15 |
Sep-5 | 34.84 | 34.25 | 35.89 | 34.07 |
Sep-6 | 34.14 | 35.02 | 36.63 | 32.47 |
Sep-9 | 34.93 | 35.13 | 37.95 | 34.00 |
Sep-10 | 35.00 | 37.93 | 37.97 | 34.80 |
Sep-11 | 37.51 | 39.34 | 40.52 | 35.57 |
Sep-12 | 39.30 | 40.36 | 42.00 | 38.63 |
Sep-13 | 40.98 | 41.95 | 43.25 | 40.66 |
Sep-16 | 42.49 | 42.76 | 43.92 | 40.70 |
Sep-17 | 43.17 | 40.27 | 44.00 | 38.17 |
Neurogene Earnings
Neurogene Earnings Report: Per Share Neurogene Earnings Q1 Q2 Q3 and Q4 last year and next year.
Neurogene Forecast Revenue Growth
Neurogene Stock Analysis: Historical quarterly revenues per share for Neurogene and historical quarterly revenue growth:
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $1.11 per share.
* Neurogene stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.